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Other names: CPETR; CPETR1; WBSCR8 
(Williams-Beuren syndrome chromosome region 8 









Intronless; one exon spanning 1.68 kb. 
Transcription 




The CLDN4 protein contains 209 amino acids and has 
a molecular weight of 22.1 kDa with four putative 
transmembrane segments. It directly interacts with 
TJP1/ZO-1, TJP2/ZO-2 and TJP3/ZO-3. 
Expression 
Claudin-4 is expressed in many fetal and adult tissue , 
predominantly in lung, intestine and kidney. 
Overexpressed in pancreatic, breast, ovarian, and 
prostate cancer. 
Localisation 
Integral membrane protein. Tight junction component. 
Function 
CLDN4 plays a major role in tight junction-specific 
obliteration of the intercellular space. 
Homology 




Williams-Beuren syndrom (WBS) includes 
supravalvular aortic stenosis (SVAS), multiple 
peripheral pulmonary arterial stenoses, elfin face, 
mental and statural deficiency, characteristic dental 
malformation, and infantile hypercalcemia. It is 
associated with an autosomal dominant contiguous 
gene deletion involving genes from chromosome band 
7q11.23, including CLDN4, elastin and LIM-kinase1. 
Haploinsufficiency for CLDN4 may be the cause of 
certain cardiovascular and musculo-skeletal 
abnormalities observed in the context of this disease. 
Gastric cancer 
Oncogenesis 
Downregulated in gastric cancer. Absence of CLDN4 
may play a role in the disruption of cell-to-cell 




Overexpressed in pancreatic cancer. Overexpression is 
predominantly observed in well-differentiated tumors 
with decreased metastatic potencial. 
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Breast cancer 
Oncogenesis 





CLDN4 is upregulated in ovarian tumors and cell lines 
and may represent a novel marker for this disease. 
Squamous cell carcinoma and Bowen's 
disease 
Oncogenesis 
Expression of claudin-4 is associated with 
keratinization in SCC and BD. 
Prostate cancer 
Oncogenesis 
Overexpressed in prostate cancer ephitelium. 
Significance unclear. 
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